Year |
Citation |
Score |
2021 |
Saminathan H, Ghosh A, Zhang D, Song C, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. Fyn Kinase-Mediated PKCδ Y311 Phosphorylation Induces Dopaminergic Degeneration in Cell Culture and Animal Models: Implications for the Identification of a New Pharmacological Target for Parkinson's Disease. Frontiers in Pharmacology. 12: 631375. PMID 33995031 DOI: 10.3389/fphar.2021.631375 |
0.764 |
|
2019 |
Blanco FA, Czikora A, Kedei N, You Y, Mitchell GA, Pany S, Ghosh A, Blumberg PM, Das J. Munc13 Is a Molecular Target of Bryostatin 1. Biochemistry. PMID 31243993 DOI: 10.1021/Acs.Biochem.9B00427 |
0.384 |
|
2017 |
Sarkar S, Malovic E, Harischandra DS, Ngwa HA, Ghosh A, Hogan C, Rokad D, Zenitsky G, Jin H, Anantharam V, Kanthasamy AG, Kanthasamy A. Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes. Neurotoxicology. PMID 28539244 DOI: 10.1016/J.Neuro.2017.05.009 |
0.731 |
|
2017 |
Langley M, Ghosh A, Charli A, Sarkar S, Ay M, Luo J, Zielonka J, Brenza T, Bennett B, Jin H, Ghaisas S, Schlichtmann B, Kim D, Anantharam V, Kanthasamy A, et al. Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice. Antioxidants & Redox Signaling. PMID 28375739 DOI: 10.1089/Ars.2016.6905 |
0.807 |
|
2016 |
Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease. Science Translational Medicine. 8: 368ra174. PMID 27928028 DOI: 10.1126/Scitranslmed.Aag2210 |
0.632 |
|
2016 |
Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, Hogan C, Sarkar S, Rokad D, Panicker N, Anantharam V, Kanthasamy AG, Kanthasamy A. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Neurobiology of Disease. PMID 27151770 DOI: 10.1016/J.Nbd.2016.04.008 |
0.762 |
|
2016 |
Ghosh A, Langley MR, Harischandra DS, Neal ML, Jin H, Anantharam V, Joseph J, Brenza T, Narasimhan B, Kanthasamy A, Kalyanaraman B, Kanthasamy AG. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 26838361 DOI: 10.1007/S11481-016-9650-4 |
0.828 |
|
2015 |
Nordström U, Beauvais G, Ghosh A, Pulikkaparambil Sasidharan BC, Lundblad M, Fuchs J, Joshi RL, Lipton JW, Roholt A, Medicetty S, Feinstein TN, Steiner JA, Escobar Galvis ML, Prochiantz A, Brundin P. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Neurobiology of Disease. 73: 70-82. PMID 25281317 DOI: 10.1016/J.Nbd.2014.09.012 |
0.613 |
|
2014 |
Jin H, Kanthasamy A, Harischandra DS, Kondru N, Ghosh A, Panicker N, Anantharam V, Rana A, Kanthasamy AG. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease. The Journal of Biological Chemistry. 289: 34743-67. PMID 25342743 DOI: 10.1074/Jbc.M114.576702 |
0.749 |
|
2014 |
Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochimica Et Biophysica Acta. 1842: 1282-94. PMID 24060637 DOI: 10.1016/J.Bbadis.2013.09.007 |
0.637 |
|
2013 |
Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, Sondarva G, Harischandra DS, Qian Z, Rana A, Kanthasamy AG. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. The Journal of Biological Chemistry. 288: 21955-71. PMID 23754278 DOI: 10.1074/Jbc.M112.444224 |
0.766 |
|
2013 |
Khasnavis S, Ghosh A, Roy A, Pahan K. Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase. The Journal of Biological Chemistry. 288: 20843-55. PMID 23744073 DOI: 10.1074/Jbc.M112.443556 |
0.565 |
|
2013 |
Dranka BP, Gifford A, Ghosh A, Zielonka J, Joseph J, Kanthasamy AG, Kalyanaraman B. Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹â´â´Â¹G) transgenic mouse. Neuroscience Letters. 549: 57-62. PMID 23721786 DOI: 10.1016/J.Neulet.2013.05.034 |
0.715 |
|
2012 |
Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Srivastava P, Dranka BP, Kalyanaraman B, Kanthasamy AG. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. Journal of Neuroinflammation. 9: 241. PMID 23092448 DOI: 10.1186/1742-2094-9-241 |
0.757 |
|
2012 |
Roy A, Ghosh A, Jana A, Liu X, Brahmachari S, Gendelman HE, Pahan K. Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease. Plos One. 7: e38113. PMID 22723850 DOI: 10.1371/Journal.Pone.0038113 |
0.488 |
|
2012 |
Lin M, Chandramani-Shivalingappa P, Jin H, Ghosh A, Anantharam V, Ali S, Kanthasamy AG, Kanthasamy A. Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells. Neuroscience. 210: 308-32. PMID 22445524 DOI: 10.1016/J.Neuroscience.2012.03.004 |
0.647 |
|
2012 |
Wong DM, Ghosh A, Fales-Williams AJ, Haynes JS, Kanthasamy AG. Evidence of oxidative injury of the spinal cord in 2 horses with equine degenerative myeloencephalopathy. Veterinary Pathology. 49: 1049-53. PMID 22390882 DOI: 10.1177/0300985812439074 |
0.517 |
|
2012 |
Dranka BP, Gifford A, Ghosh A, Kanthasamy AG, Kalyanaraman B. The NADPH Oxidase Inhibitor Diapocynin Prevents Parkinson’s Disease Symptoms in the Leucine-Rich Repeat Kinase 2 (LRRK2R1441G) Transgenic Mouse Free Radical Biology and Medicine. 53: S64. DOI: 10.1016/J.Freeradbiomed.2012.10.194 |
0.578 |
|
2011 |
Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, Kanthasamy AG. α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 2035-51. PMID 21307242 DOI: 10.1523/Jneurosci.5634-10.2011 |
0.732 |
|
2011 |
Kanthasamy AG, Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Kalyanaraman B. Anti-neuroinflammatory Effect of a Novel Compound Mito-apocynin in a Mouse Model of Parkinson's Disease Free Radical Biology and Medicine. 51: S89. DOI: 10.1016/J.Freeradbiomed.2011.10.409 |
0.603 |
|
2010 |
Ghosh A, Chandran K, Kalivendi SV, Joseph J, Antholine WE, Hillard CJ, Kanthasamy A, Kanthasamy A, Kalyanaraman B. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radical Biology & Medicine. 49: 1674-84. PMID 20828611 DOI: 10.1016/J.Freeradbiomed.2010.08.028 |
0.72 |
|
2010 |
Kanthasamy AG, Ghosh A, Joseph J, Hogan C, Anantharam V, Kanthasamy A, Kalyanaraman B. Novel NOX2 Inhibitor Suppresses Neuroinflammation in Experimental Models of Parkinson's Disease: A New Translational Strategy in Neuroprotection Free Radical Biology and Medicine. 49: S186. DOI: 10.1016/J.Freeradbiomed.2010.10.532 |
0.629 |
|
2009 |
Ghosh A, Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13543-56. PMID 19864567 DOI: 10.1523/Jneurosci.4144-09.2009 |
0.562 |
|
2009 |
Saha RN, Ghosh A, Palencia CA, Fung YK, Dudek SM, Pahan K. TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein. Journal of Immunology (Baltimore, Md. : 1950). 183: 2068-78. PMID 19596989 DOI: 10.4049/Jimmunol.0801892 |
0.361 |
|
2007 |
Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 104: 18754-9. PMID 18000063 DOI: 10.1073/Pnas.0704908104 |
0.549 |
|
Show low-probability matches. |